Akebia plans Vafseo price reset after Dec. 31, 2026 TDAPA as VOICE trial posts win odds 1.16 (NASDAQ:AKBA)
· seekingalpha.com
Akebia (AKBA) Q2 2026 earnings call recap: VOICE stopped early with Vafseo superior results, pipeline updates, and post-TDAPA pricing risks—read now.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...